Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.
FDG
amino acid PET
glioblastoma
radiation injury
target volume
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
pubmed:
5
2
2021
medline:
22
6
2021
entrez:
4
2
2021
Statut:
ppublish
Résumé
The management of patients with glioma usually requires multimodality treatment including surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for radiotherapy planning and follow-up after radiotherapy completion. In order to maximize the radiation dose to the tumor and to minimize toxic effects on the surrounding brain parenchyma, reliable identification of tumor extent and target volume delineation is crucial. The use of positron emission tomography (PET) for radiotherapy planning and monitoring in gliomas has gained considerable interest over the last several years, but Class I data are not yet available. Furthermore, PET has been used after radiotherapy for response assessment and to distinguish tumor progression from pseudoprogression or radiation necrosis. Here, the Response Assessment in Neuro-Oncology (RANO) working group provides a summary of the literature and recommendations for the use of PET imaging for radiotherapy of patients with glioma based on published studies, constituting levels 1-3 evidence according to the Oxford Centre for Evidence-based Medicine.
Identifiants
pubmed: 33538838
pii: 6128548
doi: 10.1093/neuonc/noab013
pmc: PMC8168815
doi:
Substances chimiques
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
881-893Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):591-602
pubmed: 30327856
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9
pubmed: 16168843
Neuro Oncol. 2020 Aug 17;22(8):1073-1113
pubmed: 32328653
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):886-91
pubmed: 16242251
Radiat Oncol. 2020 Apr 21;15(1):88
pubmed: 32317029
Neurology. 2015 Feb 17;84(7):710-9
pubmed: 25609769
Lancet Oncol. 2008 May;9(5):453-61
pubmed: 18452856
Pract Radiat Oncol. 2018 Jul - Aug;8(4):230-238
pubmed: 29730279
BMC Cancer. 2016 Oct 5;16(1):769
pubmed: 27716184
Neuroimage. 2007 Sep 1;37(3):866-75
pubmed: 17616402
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):479-85
pubmed: 18834673
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1476-1485
pubmed: 32025750
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1487-95
pubmed: 20399573
J Nucl Med. 2007 Dec;48(12):2056-62
pubmed: 18006612
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):499-508
pubmed: 16517093
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1468-1475
pubmed: 31953672
J Neurosurg. 2019 Sep 21;131(3):676-686
pubmed: 30239314
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1024-1028
pubmed: 29913253
IEEE Trans Med Imaging. 2019 Aug;38(8):1875-1884
pubmed: 30835219
Eur J Radiol. 2018 Jun;103:32-37
pubmed: 29803382
Acta Radiol. 1989 May-Jun;30(3):225-32
pubmed: 2660886
Methods. 2021 Apr;188:112-121
pubmed: 32522530
Radiother Oncol. 2020 Apr;145:49-55
pubmed: 31923709
Neuro Oncol. 2014 Apr;16(4):603-9
pubmed: 24305722
Radiat Oncol. 2008 Dec 24;3:44
pubmed: 19108742
Radiother Oncol. 2013 Dec;109(3):487-92
pubmed: 23953407
Neuro Oncol. 2019 May 6;21(5):585-595
pubmed: 30615138
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):685-95
pubmed: 25411133
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Radiother Oncol. 2016 Jan;118(1):35-42
pubmed: 26777122
Clin Cancer Res. 2014 Oct 1;20(19):5023-31
pubmed: 25107913
J Neurooncol. 2012 Dec;110(3):389-95
pubmed: 23054562
J Nucl Med. 2012 Aug;53(8):1253-61
pubmed: 22743251
Neuro Oncol. 2015 May;17(5):757-63
pubmed: 25537018
Med Phys. 2019 Jan;46(1):e1-e36
pubmed: 30367497
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58
pubmed: 21570201
PLoS One. 2016 Jun 08;11(6):e0157139
pubmed: 27276226
J Nucl Med. 2002 Dec;43(12):1667-73
pubmed: 12468518
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):83-9
pubmed: 21095072
Neuro Oncol. 2011 Mar;13(3):307-16
pubmed: 21292686
J Neurooncol. 2017 Apr;132(2):277-286
pubmed: 28102485
Neuro Oncol. 2020 Jan 11;22(1):17-30
pubmed: 31437274
Clin Cancer Res. 2012 Jan 1;18(1):273-9
pubmed: 22065084
J Nucl Med. 2014 Oct;55(10):1611-6
pubmed: 25125481
Sci Rep. 2018 May 8;8(1):7201
pubmed: 29740097
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52
pubmed: 10924970
Neurooncol Pract. 2020 Mar;7(2):152-157
pubmed: 32206320
Radiol Clin North Am. 2019 Nov;57(6):1199-1216
pubmed: 31582045
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):515-22
pubmed: 17900820
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1025-35
pubmed: 23525498
Clin Cancer Res. 2002 Apr;8(4):971-9
pubmed: 11948102
J Nucl Med. 2012 Jul;53(7):1048-57
pubmed: 22645298
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):569-579
pubmed: 30109401
Neuroimage Clin. 2018 Aug 19;20:537-542
pubmed: 30175040
Front Oncol. 2020 Feb 11;10:12
pubmed: 32117704
Radiother Oncol. 2019 Jan;130:121-131
pubmed: 30219612
Semin Nucl Med. 2017 Jan;47(1):5-17
pubmed: 27987557
Adv Radiat Oncol. 2019 Sep 07;5(1):53-61
pubmed: 32051890
PLoS One. 2018 Apr 13;13(4):e0195798
pubmed: 29652908
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
J Neurosurg. 2016 Jul;125(1):17-23
pubmed: 26544782
Eur Radiol. 2013 Sep;23(9):2628-35
pubmed: 23624623
Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):243-52
pubmed: 6260715
Clin Cancer Res. 2004 Nov 1;10(21):7163-70
pubmed: 15534088
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1889-1901
pubmed: 31203420
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):373-381
pubmed: 27554774
N Engl J Med. 2017 Nov 16;377(20):1954-1963
pubmed: 29141164
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):331-8
pubmed: 16839701
AJNR Am J Neuroradiol. 2013 May;34(5):944-50, S1-11
pubmed: 23124638
Neuro Oncol. 2020 Mar 5;22(3):412-422
pubmed: 31550353
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2230-2238
pubmed: 28821920
Neuro Oncol. 2020 Jul 7;22(7):1030-1043
pubmed: 32047908
J Neurosurg. 1999 Aug;91(2):251-60
pubmed: 10433313
Radiother Oncol. 2018 Apr;127(1):121-127
pubmed: 29433917
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):38-44
pubmed: 29102648
J Nucl Med. 2008 Apr;49(4):515-6
pubmed: 18375922
J Clin Oncol. 2012 Jul 20;30(21):e180-3
pubmed: 22689800
Neuro Oncol. 2016 Nov;18(11):1538-1547
pubmed: 27106404
Radiology. 2000 Nov;217(2):377-84
pubmed: 11058631
J Neurooncol. 2012 May;107(3):527-35
pubmed: 22169956
Anticancer Res. 2016 Oct;36(10):4985-4995
pubmed: 27798857
Neuro Oncol. 2013 Aug;15(8):1058-67
pubmed: 23460322
Cancer. 1997 Jan 1;79(1):115-26
pubmed: 8988735
J Nucl Med. 2006 Jun;47(6):904-11
pubmed: 16741298
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1458-1467
pubmed: 31919633
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74
pubmed: 16111573
Radiat Oncol. 2014 Aug 14;9:181
pubmed: 25123357
Br J Radiol. 2019 Jul;92(1099):20180901
pubmed: 31017449
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1383-1392
pubmed: 28315948
Radiat Oncol. 2016 Jun 24;11:87
pubmed: 27342976
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1561-7
pubmed: 14579097
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590
pubmed: 30244386
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):176-84
pubmed: 20646863
Strahlenther Onkol. 2020 Oct;196(10):856-867
pubmed: 32394100
JAMA Oncol. 2018 Aug 1;4(8):1123-1124
pubmed: 29327059
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1100-6
pubmed: 24161427
Strahlenther Onkol. 2012 Apr;188(4):334-9
pubmed: 22349712
Radiother Oncol. 2017 Nov;125(2):223-227
pubmed: 29054380
Mol Imaging. 2013 May;12(3):137-47
pubmed: 23490440
J Nucl Med. 2012 Jul;53(7):1058-64
pubmed: 22653792
Radiother Oncol. 2011 Apr;99(1):44-8
pubmed: 21458093
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1368-1380
pubmed: 31486876
Radiother Oncol. 2009 Dec;93(3):586-92
pubmed: 19782417
Clin Cancer Res. 2016 May 1;22(9):2190-6
pubmed: 26673798
Biomed Res Int. 2014;2014:407026
pubmed: 24977151
Brain. 2005 Mar;128(Pt 3):678-87
pubmed: 15689365
JAMA Oncol. 2020 Apr 1;6(4):495-503
pubmed: 32027343
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):238-239
pubmed: 29705720
Neuro Oncol. 2019 Dec 17;21(12):1595-1606
pubmed: 31618420
Neuro Oncol. 2017 May 1;19(5):625-635
pubmed: 28453751
Lancet Oncol. 2019 May;20(5):728-740
pubmed: 30952559
Front Pharmacol. 2019 Jul 10;10:772
pubmed: 31354487